Scientists launch study to decode why diabetes affects people differently
NCT ID NCT07670871
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
The EXPAND study is a research project that will enroll 440 adults with and without pancreatic conditions to understand why type 2 diabetes varies so much from person to person. Researchers will collect data on metabolism, genetics, and pancreas health to identify distinct diabetes subtypes. This is an observational study, meaning no new treatments are being tested, but the findings could pave the way for more personalized diabetes care in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could lead to better ways to classify and treat different types of diabetes based on individual biology.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly benefit participants. Results may take years to influence clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE PANCREATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pancreatic Cancer's inflammatory footprint be stopped?
- A new rice could tame blood sugar spikes in prediabetes
- Blood and gut clues may flag pancreatic cancer risk early
- Can a new imaging trick spot pancreatic cancer without a biopsy?
- Could everyday supplements turn back the clock on aging?
- Can a new drug combo shrink Hard-to-Treat tumors?